Authors: OSTERLIND A STENDER IM HEINAVAARA S

Citation: A. Osterlind et al., WHAT DO DANES KNOW ABOUT NEVI, SKIN-CANCER AND MELANOMA - EXPERIENCE FROM A DERMATOLOGICAL OUTPATIENT-CLINIC, Melanoma research, 7(1), 1997, pp. 69-73

Authors: AHTILA S KAAKKOLA S GORDIN A KORPELA K HEINAVAARA S KARLSSON M WIKBERG T TUOMAINEN P MANNISTO PT

Citation: S. Ahtila et al., EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON THE PHARMACOKINETICS AND METABOLISM OF LEVODOPA AFTER ADMINISTRATION OF CONTROLLED-RELEASE LEVODOPA-CARBIDOPA IN VOLUNTEERS, Clinical neuropharmacology, 18(1), 1995, pp. 46-57

Authors: ILLI A SUNDBERG S KOULU M SCHEININ M HEINAVAARA S GORDIN A

Citation: A. Illi et al., COMT INHIBITION BY HIGH-DOSE ENTACAPONE DOES NOT AFFECT HEMODYNAMICS BUT CHANGES CATECHOLAMINE METABOLISM IN HEALTHY-VOLUNTEERS AT REST ANDDURING EXERCISE, International journal of clinical pharmacology and therapeutics, 32(11), 1994, pp. 582-588

Authors: SANKILA R HEINAVAARA S HAKULINEN T

Citation: R. Sankila et al., SURVIVAL OF BREAST-CANCER PATIENTS AFTER SUBSEQUENT TERM PREGNANCY - HEALTHY MOTHER EFFECT, American journal of obstetrics and gynecology, 170(3), 1994, pp. 818-823